Evaluating the Efficacy and Effectiveness of SCOPE - RCT
SCOPERCT
Efficacy and Effectiveness of SCOPE for Intellectually Able Youths With Autism Spectrum Disorder- a Randomized Controlled Study
1 other identifier
interventional
144
1 country
1
Brief Summary
The study will entail an evaluation of the feasibility, acceptability, efficacy and effectiveness of SCOPE coach supported internet-delivered psychoeducative program using a randomized controlled design in a clinical health care context. An estimated n=175 will be needed to enable block randomisation according a 2:1:1 ratio to: 1) SCOPE internet-based psychoeducation intervention, 2) Self-study controls, who receive eight weekly emails containing informative and relevant websites about Autism Spectrum Disorder (ASD), 3) Wait-list controls.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
September 3, 2018
CompletedFirst Posted
Study publicly available on registry
September 11, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 9, 2021
CompletedDecember 13, 2021
December 1, 2021
5 years
September 3, 2018
December 9, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in scores on the ASD Knowledge Quiz
16 questions about general knowledge about ASD. The questions are based on the eight modules in the interventions.
Change in knowledge measured at baseline, immediately after the intervention and at three month follow-up
Secondary Outcomes (3)
Hospital Anxiety and Depression Scale
Measured at baseline, immediately after the intervention and at three month follow-up
Acceptance and Action Questionnaire (AAQ-II)
Measured at baseline, immediately after the intervention and at three month follow-up
Brunnsviken Brief Quality of Life Inventory (BBQ)
Measured at baseline, immediately after the intervention and at three month follow-up
Other Outcomes (1)
The Treatment Credibility Scale (TCS)
Measured at baseline, immediately after the intervention and at three month follow-up
Study Arms (3)
SCOPE
EXPERIMENTALParticipants allocated to SCOPE, will receive an internet-based psychoeducation intervention, eight weeks of ASD-theme modules with coaching.
Self-study
ACTIVE COMPARATORParticipants allocated to self-study will receive eight weekly emails containing informative and relevant websites about ASD. The emails are accessed on the same platform as the experimental condition (SCOPE), no active contact with the coaches is available.
Wait-list controls/Treatment as usual
NO INTERVENTIONParticipants allocated to wait-list will receive prompts to answer outcome measures but otherwise no other contact with the study coordinators or coaches. Participants may receive treatment as usual.
Interventions
SCOPE is a internet-delivered, coach-guided, psychoeducational intervention, intended to serve as a first-line intervention for intellectually able adolescents and young adults with ASD. The SCOPE program is based on information comprising neuropsychology, pedagogy, and also interdisciplinary clinical experience regarding ASD. The content is aimed at providing information about typical and specific impairments of ASD, as well as the associated strengths.
Eligibility Criteria
You may qualify if:
- diagnosed autism spectrum disorder with IQ in the average range (\>70) (diagnosed in accordance with the DSM or ICD-10 diagnostic manuals)
- relevant age group (16 to 25 years)
- active participation in the eight-week program
- sufficient Swedish language proficiency
- ability to log on and utilize an internet-based platform
You may not qualify if:
- current substance misuse (including the past three months)
- suicidal ideation,
- diagnosed with intellectual disability (according to DSM or ICD),
- diagnosed with traumatic brain injury (e.g., stroke),
- other severe psychiatric disorders (e.g., psychosis) or adverse psychosocial circumstances (e.g., being homeless) that would render participation unlikely or impossible.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska Institutetlead
- Stiftelsen Promobiliacollaborator
- Stiftelsen Sunnerdahls Handikappfondcollaborator
- Stiftelsen Sven Jerrings fondcollaborator
- L.J. Boëthius stiftelsecollaborator
- Stiftelsen Frimurarna Barnhusetcollaborator
- Stockholm County Council ALF/PPGcollaborator
Study Sites (1)
Habilitering & Hälsa
Stockholm, Stockholm County, Sweden
Related Publications (1)
Backman A, Roll-Pettersson L, Mellblom A, Norman-Claesson E, Sundqvist E, Zander E, Vigerland S, Hirvikoski T. Internet-Delivered Psychoeducation (SCOPE) for Transition-Aged Autistic Youth: Pragmatic Randomized Controlled Trial. J Med Internet Res. 2024 Nov 28;26:e49305. doi: 10.2196/49305.
PMID: 39608000DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tatja Hirvikoski, Associate Professor
Karolinska Insitutet
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 3, 2018
First Posted
September 11, 2018
Study Start
September 1, 2016
Primary Completion
August 31, 2021
Study Completion
December 9, 2021
Last Updated
December 13, 2021
Record last verified: 2021-12